Inhibition of gastrointestinal and liver hexosamine synthesis by sodium salicylate and ethanol.
D000818:Animals; D001241:Aspirin / Q000009:adverse effects*; D003864:Depression, Chemical; D000431:Ethanol / Q000009:adverse effects*; D005753:Gastric Mucosa / Q000378:metabolism*; D005945:Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) / Q000032:analysis; D006595:Hexosamines / Q000096:biosynthesis*; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D051381:Rats; D013270:Stomach / Q000187:drug effects
D006595:Hexosamines; D000431:Ethanol; D005945:Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing); D001241:Aspirin